53859-71-5 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 22 carbon (C) atoms, 19 hydrogen (H) atoms, 5 nitrogen (N) atoms, and 1 oxygen (O) atom.
Explanation
Urea derivatives are a group of compounds that have a urea functional group (-NH-CO-NH2) attached to other chemical structures. This compound belongs to this class, as it has a urea molecule with two 1H-benzoimidazol-2-yl-phenyl groups attached.
Explanation
The compound's structure consists of a central urea molecule with two 1H-benzoimidazol-2-yl-phenyl groups connected to it. These groups are derived from benzimidazole, a heterocyclic compound with potential biological activities.
Explanation
Due to its unique structure, this compound may have the ability to interact with different biological targets, such as enzymes, receptors, or other proteins. These interactions could lead to potential pharmacological and biological activities, making it a candidate for further research in the field of medicinal chemistry.
Explanation
The compound's potential pharmacological and biological activities make it an interesting subject for research in the fields of medicinal chemistry and pharmaceutical research. Its unique structure and interactions with biological targets could lead to the development of new drugs or therapies for various diseases and conditions.
Explanation
The compound contains benzimidazole, a heterocyclic compound with a fused benzene and imidazole ring. Heterocyclic compounds are often found in biologically active molecules and can contribute to the compound's pharmacological and biological properties.
Explanation
The compound's structure, including the urea and benzimidazole moieties, may provide it with a certain level of chemical stability, allowing it to maintain its properties in different environments, such as in the presence of enzymes or under various pH conditions.
Explanation
The compound's structure suggests that it can be synthesized through various chemical reactions, such as condensation reactions between the urea molecule and the 1H-benzoimidazol-2-yl-phenyl groups. This allows for the exploration of different synthetic routes and optimization of the compound's properties.
Explanation
The compound's structure allows for the potential modification and optimization of its properties by introducing different substituents or functional groups. This structural diversity can lead to the development of more potent or selective compounds for specific applications.
Explanation
The compound's structure and properties can be analyzed and confirmed using various analytical techniques, such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and X-ray crystallography. These techniques provide valuable information about the compound's molecular structure, conformation, and interactions with other molecules.
Class
Urea derivatives
Structure
Two 1H-benzoimidazol-2-yl-phenyl groups attached to a urea molecule
Pharmacological and biological activities
Potential interactions with various biological targets
Interest in medicinal chemistry and pharmaceutical research
Potential applications in drug development
Heterocyclic compounds
Presence of benzimidazole in the structure
Chemical stability
Potential for stability in various environments
Synthesis
Potential for chemical synthesis through various routes
Structural diversity
Possibility for further modification and optimization
Analytical techniques
Characterization using techniques such as NMR, mass spectrometry, and X-ray crystallography
Check Digit Verification of cas no
The CAS Registry Mumber 53859-71-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,8,5 and 9 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 53859-71:
(7*5)+(6*3)+(5*8)+(4*5)+(3*9)+(2*7)+(1*1)=155
155 % 10 = 5
So 53859-71-5 is a valid CAS Registry Number.
53859-71-5Relevant articles and documents
Molecular docking guided structure based design of symmetrical N,N′-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors
Sivan, Sree Kanth,Vangala, Radhika,Manga, Vijjulatha
, p. 4591 - 4599 (2013/07/26)
Induced fit molecular docking studies were performed on BMS-806 derivatives reported as small molecule inhibitors of HIV-1 gp120-CD4 binding. Comprehensive study of protein-ligand interactions guided in identification and design of novel symmetrical N,N′-disubstituted urea and thiourea as HIV-1 gp120-CD4 binding inhibitors. These molecules were synthesized in aqueous medium using microwave irradiation. Synthesized molecules were screened for their inhibitory ability by HIV-1 gp120-CD4 capture enzyme-linked immunosorbent assay (ELISA). Designed compounds were found to inhibit HIV-1 gp120-CD4 binding in micromolar (0.013-0.247 μM) concentrations.
(BENZIMIDAZOL-2-YL)-PHENYL-PHENYL-UREA COMPOUNDS AND METHODS FOR INHIBITING HEPARANASE ACTIVITY
-
Page/Page column 33, (2010/02/11)
The present invention encompasses heparanase inhibitors, particularly to certain (benzimidazol-2-yl)-phenyl-phenyl-urea derivatives that inhibit heparanase, pharmaceutical compositions that contain the compounds, methods for making the compounds, and meth
